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Abstract: Withania somnifera (Ashwagandha) root extract contains lot of biologically active metabolites, which have a broad 
range of pharmacological activities. The current study was designed to evaluate the effects of The Trivedi Effect® - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing Treatment) on the physical, spectroscopic, thermal and behavioral 
properties of ashwagandha root extract using PXRD, PSD, FT-IR, UV-vis spectroscopy, TGA, and DSC analysis. Ashwagandha root 
extract was divided into two parts – one part was control without any Biofield Energy Treatment and another part was treated with the 
Energy of Consciousness Healing Treatment remotely by seven renowned Biofield Energy Healers and defined as The Trivedi 
Effect® treated sample. The PXRD analysis exhibited that both the treated and control samples were amorphous in nature. The 
particle size values at d10, d50, and d90 of the treated sample were decreased by 8.41%, 0.51%, and 7.88%, respectively compared with 
the control sample. The surface area analysis revealed that the surface area of the treated sample was significantly increased by 5% 
compared to the control sample. The FT-IR analysis indicated the alteration of the force constant for the functional groups of the 
treated sample in comparison to the control sample. The UV-vis analysis revealed that the wavelength for the maximum absorbance 
of the control and treated samples were at 205.3 and 205.0 nm, respectively. The TGA analysis revealed that the total weight loss was 
decreased by 0.65% in the treated sample compared with the control sample. The DSC analysis indicated that the onset, peak, and 
endset vaporization temperature of the treated sample were significantly increased by 41.97%, 23.51%, and 8.82%, respectively as 
compared to the control sample. The latent heat of vaporization (∆H) of the treated (239.96 J/g) sample was significantly increased by 
39.84% compared with the control (171.60 J/g) sample. This indicated that the treated sample was thermally more stable as compared 
to the control sample. The current findings suggested that The Trivedi Effect® - Energy of Consciousness Healing Treatment 
(Biofield Energy Healing) might have the astounding capacity to enhance the solubility, absorption, dissolution, and bioavailability of 
ashwagandha root extract in various form of pharmaceutical and nutraceutical formulation by modifying its particle size and surface 
area. Thus, the treated ashwagandha root extract might provide better therapeutic response against against inflammatory diseases, 
immunological disorders, stress, arthritis, cancer, diabetes, sexual disorders, aging and other chronic infections. 
Keywords: Withania somnifera, Biofield Energy Healing Treatment, Biofield Energy Healers,  
Consciousness Energy Healing, The Trivedi Effect®, Particle Size, TGA, DSC 
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1. Introduction 
The importance of the herbal medicines in the prevention 
and treatment of the various diseases have been increased 
day-by-day throughout the world due to its impressive 
therapeutic effects and fewer side effects as compared to the 
modern medicines [1]. The roots of Withania somnifera (L.) 
Dunal (Family- Solanaceae) - a vital Rasayana herb is 
traditionally known as ‘Ashwagandha’ or winter cherry. In 
Ayurveda, it is called as ‘Indian ginseng’. Ashwagandha is 
widely used in the most of the Indian herbal drugs and 
nutraceuticals for the treatment of various diseases including 
nervous and sexual disorders, infectious diseases, diabetes, 
cancer, ulcer, immunological disorders, stress, arthritis, etc. 
From the ancient time, it is used as a tonic to arrest the 
ageing process, rejuvenate the body and boost the defense 
against infectious disorders and also promote the longevity 
[2-11]. As ashwagandha root extract contains a wide array of 
nutrients and phytochemicals, it is used as a dietary 
supplement for the health restoration [3]. The major active 
phytoconstituents of ashwagandha root extract are highly 
oxygenated withanolides. Withanolides have C28 steroidal 
nucleus with C9 side chain, having a six membered lactone 
ring (Figure 1). The oxidation at various sites of skeleton is 
responsible for the structural deviations in different classes of 
withanolides [11-14].  
 
Figure 1. Basic skeleton of withanolide. 
Literatures reported that withanolides such as withaferin 
A, withanolide D, withanolide E, etc. possess various 
pharmacological activities including antioxidant, anticancer, 
immunomodulating, neuroprotective, antiepileptic, 
antibacterial, adaptogenic, spermatogenic, antidepression, 
antianxiety, hepatoprotective, anti-inflammatory, antiarthritic, 
antimicrobial, hypoglycaemic, hypolipidemic, aphrodisiac, 
antiulcer, radiosensitizing, etc. [11, 14-19]. Therefore, a new 
proprietary herbomineral formulation was formulated that 
consisted of herbal product like ashwagandha root extract 
along with minerals such as zinc, magnesium and selenium. 
This herbomineral formulation is designed as nutraceutical 
supplement and can be used for the prevention and treatment 
of various human disorders.  
From the ancient-time, the living force preserved by every 
living organisms that contributes the ‘life’ is defined as prana 
by the Hindus, qi or chi by the Chinese, and ki by the 
Japanese. This is believed to co-relate with the soul, spirit 
and mind. This hypothetical vital force is considered now as 
the Bioenergetics Field. The Biofield Energy Field is a 
dynamic electromagnetic field existing surround of the 
human body. The Biofield Energy is infinite and 
paradimensional. It can freely flow between the human and 
environment that leads to the continuous movement or matter 
of energy [20, 21]. Thus, the human has the ability to harness 
energy from the earth, the “universal energy field” and 
transmit it to any living or nonliving object (s) around the 
globe. The objects always receive the energy and respond in 
a useful way. This process is known as Biofield Energy 
Healing Treatment [22, 23]. Biofield (Putative Energy Fields) 
based Energy Therapies are used worldwide to promote 
health and healing [24]. The National Center of 
Complementary and Integrative Health (NCCIH) has been 
recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy, and applied prayer (as is 
common in all religions, like Christianity, Hinduism, 
Buddhism and Judaism) [25]. The Biofield Energy Treatment 
(The Trivedi Effect®) has been extensively studied with 
significant outcomes in many scientific fields such as cancer 
research [26]; altered antimicrobial sensitivity of pathogenic 
microbes in microbiology [27-29], biotechnology [30, 31], 
genetics [32, 33]; altered structure of the atom in relation to 
the various metals, ceramics, polymers and chemicals 
materials science [34-36]; altered physical and chemical 
properties of pharmaceuticals [37, 38], nutraceuticals [39, 
40], organic compounds [41-43]; and improved overall 
growth and yield of plants in agricultural science [44, 45]. 
Herbal extracts and it’s formulations despite of their 
outstanding in vitro results exhibited poor or negligible in 
vivo activity, because of their low lipid solubility or improper 
molecular size, causing in deprived absorption and thus poor 
bioavailability [1]. According to the recent study on the 
bioavailability of major withanolides of Withania somnifera, 
Devkar et al. demonstrated that the nonpolar and low 
molecular weight withanolides are highly permeable, 
whereas the high glycosylated and polar withanolides 
displayed low permeability in their in vitro absorption model 
system [46]. For instance, ashwagandha root extract has the 
outstanding nutrition and medicinal values, researchers are 
still working on to find out an optimal dosage range for 
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reproducing the desired effects in human as well as to 
determine the safe, non-toxic and effective dosage form [47]. 
The physicochemical properties such as particle size, 
crystalline structure, crystallite size, surface area, etc. and 
thermal properties of a drug play a vital role in bioavailability 
as well as stability of the drug during processing, 
formulation, storage, and packaging [48, 49]. Biofield 
Energy Treatment (The Trivedi Effect®) has been reported to 
change the particle size, specific surface area, crystalline, 
chemical and thermal behavior of an atom/ion through 
possible mediation of neutrinos [50]. By considering all these 
aspect, the objective of the current study was to examine 
whether the Biofield Energy Treatment can change the 
physical, structural, and thermal properties of ashwagandha 
root extract in such a way that might be assist in the 
improvement of the solubility and absorption of 
ashwagandha root extract and also help in designing of any 
suitable pharmaceutical formulation. The physical, 
spectroscopic, and thermal properties of both control and the 
Biofield Energy Treated ashwagandha root extracts were 
evaluated using various analytical techniques include Fourier 
transform infrared (FT-IR) spectrometry, ultraviolet-visible 
(UV-vis) spectroscopy, Powder X-ray diffraction (PXRD), 
particle size distribution analysis (PSD), thermogravimetric 
analysis (TGA), and differential scanning calorimetry (DSC). 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Withania somnifera (Ashwagandha) root hydroalcoholic 
extract was purchased from Sanat Product Ltd., India. All 
other chemicals used in the experiment were of analytical 
grade available in India.  
2.2. Energy of Consciousness Healing Treatment Strategies 
Ashwagandha root extract powder was one of the 
components of the new proprietary herbomineral 
formulation, developed by our research team, and it was used 
per se as the test compound for the current study. The test 
compound was divided into two parts, one part of the test 
compound was treated with The Trivedi Effect® - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing) 
by renowned Biofield Energy Healers and defined as The 
Trivedi Effect® treated sample, while the second part of the 
test compound did not receive any sort of such treatment and 
defined as untreated or control ashwagandha root extract 
sample. The Trivedi Effect® treatment was provided by the 
group of seven renowned Biofield Energy Healers who 
participated in this study and performed the Biofield Energy 
Treatment (The Trivedi Effect®) remotely. All seven Biofield 
Energy Healers were remotely located in the U.S.A., while 
the test compound was located in the research laboratory of 
GVK Biosciences Pvt. Ltd., Hyderabad, India. This The 
Trivedi Effect® - Energy of Consciousness Healing 
Treatment was provided for 5 minutes through Healer’s 
Unique Energy Transmission process remotely to the test 
compound under the laboratory conditions. None of the 
Biofield Energy Healers in this study visited the laboratory in 
person, nor had any contact with the compounds. Similarly, 
the control compound was subjected to “sham” healers for 5 
minutes, under the same laboratory conditions. The sham 
healer did not have any knowledge about Biofield Energy 
Treatment. After that, the treated and untreated samples were 
kept in similar sealed conditions and characterized 
thoroughly by PXRD, PSD, FT-IR, UV-visible spectroscopy, 
TGA, and DSC analysis.  
2.3. Characterization 
2.3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the XRD results, the 
crystallite size (G) was calculated using X’pert data collector 
and X’pert high score plus processing software. A total of 
~500 mg of the control and treated samples individually were 
used for the analysis and prepared by back loading technique 
using the sample preparation kit. The sample was spread on 
the holder ring in sufficient quantity to fill the ring cavity. It 
was then pressed down using powder press block and scrap 
the powder that was in surplus using a glass slide to get 
densely packed specimen. Consequently, the bottom plate 
was placed onto the holder ring and clamp in position. The 
sample holder was then removed from the sample preparation 
table by turning it upside down. A smooth surface of sample 
was obtained to ensure optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with the dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and the 
background measurement was taken. After the background 
measurement, the sample was added in to the sample unit 
with constant monitoring the obscuration and stopped the 
addition of sample when the obscuration reached in between 
15% to 20%. When the obscuration was stable, the 
measurement was taken twice and the average was taken of 
two measurements. The average histogram of the two 
measurements was recorded. Along with histogram, the data 
was presented in table format which include particle size 
(µm). Also, the values at below 10% level (d10), 50% level 
(d50), and 90% level (d90), were calculated from the 
histogram and the calculations such as surface area (m2/g) 
were done by using software Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation 1: 
31 Mahendra Kumar Trivedi et al.:  Effects of the Energy of Consciousness Healing Treatment on Physical, Spectroscopic,   
Thermal and Behavioral Properties of Ashwagandha Root Extract 
%	change	in	particle	size    1   (1) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10) 50% level (d50) and 90% level (d90) of 
the control and treated samples, respectively. 
Percent change in surface area (S) was calculated using 
following equation 2: 
%	change	in	surface	area  #	#	#	  100	   (2) 
Where, SControl and STreated are the surface area of the 
control and treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy  
FT-IR spectroscopy of ashwagandha root extract was 
performed on Spectrum two (Perkin Elmer, USA) Fourier 
transform infrared spectrometer with the frequency array of 
400-4000 cm-1 by using pressed KBr disk technique. 
2.3.4. Ultra Violet-visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength range chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Thermal Gravimetric Analysis (TGA) 
TGA analysis was performed using Instrument TGA Q50 
(TA Instruments, USA) at a heating rate of 10ºC/min from 
room temperature i.e. 30ºC to 900°C under nitrogen 
atmosphere. A total of ~13 mg of sample was used for the 
analysis and was taken on the platinum pan. In TGA, the 
weight loss for each step was recorded in grams as well as in 
percent loss with respect to the initial weight. Also, the onset, 
endset, and peak temperature for each step were recorded in 
TGA.  
Percent change in weight loss (W) was calculated using 
following equation 3: 
%	change	in	weight	loss  '	'	'	  100   (3) 
Where, WControl and WTreated are the weight loss of the 
control and The Trivedi Effect® treated samples, respectively. 
2.3.6. Differential Scanning Calorimetry (DSC) 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~4 mg sample was weighed and sealed in aluminum pan 
and equilibrated at 25°C and heated up to 450ºC at the 
heating rate of 10ºC/min under nitrogen gas as purge 
atmosphere with flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in melting point (T) was calculated using 
following equation 4: 
%	change	in	melting	point  )))  100   (4) 
Where, TControl and TTreated are the melting point of the 
control and treated samples, respectively. 
Percent change in latent heat of fusion (∆H) was calculated 
using following equation 5: 
%	change	in	latent	heat	of	fusion  *+,+,+  100 (5) 
Where, ∆HControl and ∆HTreated are the latent heat of fusion 
of the control and treated samples, respectively. 
3. Results and Discussion 
3.1. Powder X-ray Diffraction (PXRD) Analysis  
Powder X-ray diffraction study was conducted to examine 
the crystalline pattern of the control and treated ashwagandha 
root extract. The PXRD diffractograms of the control and 
treated ashwagandha root extracts did not contribute any 
diffraction peak and it was concluded that both the samples 
were amorphous in nature (Figure 2).  
 
Figure 2. PXRD diffractograms of the control and Biofield Energy Treated 
W. somnifera (Ashwagandha) root extract. 
3.2. Particle Size Distribution (PSD) Analysis 
Particle size data (d10, d50, and d90) of both the control and 
treated ashwagandha root extract was investigated and the 
results are presented in Table 1. The particle size values at 
d10, d50, and d90 of the Biofield Energy Treated ashwagandha 
root extract (d10 = 20.90 µm, d50 = 70.83 µm, and d90 = 
158.76 µm) were reduced by 8.41%, 0.51%, and 7.88%, 
respectively with respect to the control sample (d10 = 22.82 
µm, d50 = 71.19 µm, and d90 = 172.34 µm).  
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Table 1. Particle size (d10, d50, and d90) and surface area of the control and 
Biofield Energy Treated W. somnifera (Ashwagandha) root extract. 
Parameter d10 (µm) d50 (µm) d90 (µm) 
Surface area 
(m2/g) 
Control 22.82 71.19 172.34 0.20 
Biofield Energy 
Treated 
20.90 70.83 158.76 0.21 
Percent change (%) * -8.41 -0.51 -7.88 5.00 
*denotes the percentage change in the particle size (d10, d50, and d90) and 
surface area of the Biofield Energy Treated sample with respect to the 
control sample. 
The results revealed that there may be an effect of high 
energy milling induced through the Biofield Energy 
Treatment to the ashwagandha root extract. The surface area 
analysis of both the control and treated ashwagandha root 
extract revealed that the surface area of the Biofield Energy 
Treated ashwagandha root extract (0.21 m2/g) was enhanced 
by 5% from the control sample (0.20 m2/g). Numerous 
literatures mentioned that particle size, shape and surface 
area of the pharmaceuticals/nutraceuticals have an important 
impact on solubility, dissolution, in vivo bioavailability, dose 
uniformity and therapeutic efficacy as well as assist in the 
design of the new drug delivery systems [51]. Decrease in 
particle size and higher surface area increase the solubility of 
the solid particles as well as enhance the dissolution rate and 
bioavailability [52]. Thus, it is anticipated that The Trivedi 
Effect® treated ashwagandha root extract might be absorbed 
in faster rate and thus, can provide better bioavailability than 
the untreated sample.  
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of both the control and Energy of 
Consciousness Healing Treated samples of ashwagandha root 
extract are presented in Figure 3. 
 
Figure 3. FT-IR spectra of the control and Biofield Energy Treated W. somnifera (Ashwagandha) root extract. 
The wavenumber of the absorbance ν of a diatomic can be 
calculated from the following equation derived from the 
Hooke’s law (Eq. 6): 
-  ./0123	456	7	5895658                             (6) 
Where, v = vibrational frequency (cm-1), c = the velocity of 
light (cm/s), m1 and m2 = the mass of atoms 1 and 2, 
respectively, in g, f = the force constant of the bond 
(dyne/cm). 
From the above equation (6), it has been shown that if 
other factors remain constant, the vibrational frequency 
(wavenumber) is directly proportional to the force constant 
i.e. for a certain functional group (for e.g. -C=O), changes in 
the vibrational frequency (wavenumber) indicate the 
alteration of the force constant. Several factors such as 
hybridization, resonance, bond strength, conjugation, etc. can 
affect the force constant [53, 54]. 
From the Table 2, it has been observed that the 
wavenumber for the O-H stretching, C-O alkoxy groups of 
Biofield Energy Treated ashwagandha (Table 2, entry 1 and 
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5) were increased compared with the control sample. It 
indicated that the force constant of the O-H and C-O groups 
were improved. On the other hand, the wavenumber for C-H 
(alkene), C=O, C-O groups (Table 2, entry 2, 3, 4, and 6) was 
reduced as compared to the control sample. This results 
revealed that the force constant for the C-H (alkene), C=O, 
C-O groups was diminished as compared to the control 
sample. 
Table 2. FT-IR data of the control and Biofield Energy Treated W. somnifera 
(Ashwagandha) root extracts. 
Entry 
No. 
Mode of vibration 
Characteristic absorption (s) of 
ashwagandha root extract (cm-1) 
Control 
The Trivedi 
Effect®Treated 
1 O-H stretching 3404 3417 
2 C-H, alkanes stretching 2929 2929 
3 
C=O stretching (α, β-
unsaturated ketone) 
1690 1685 
4 C-H, alkanes bending 1410 1384 
5 C-O in alkoxy 
1121 
1019 
1126 
1030 
6 C-H aromatic bending 632 619 
It is assumed that the alteration of the force constant for 
the functional groups might be due to the change in the bond 
strength of the functional groups of the treated sample 
compared to the control sample. The presence of epoxide, 
unsaturated lactone, 1-keto-2-ene functions play a vital role 
to elicit the pharmacological activities of withanolides [14, 
55-57]. From the Table 2, it has been found that these type of 
functional groups were altered in the treated ashwagandha in 
comparison to the control sample. Hence, it is assumed that 
The Trivedi Effect® treatment might be responsible for 
changing the structural features of the ashwagandha root 
powder extract.  
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and treated 
ashwagandha root extracts are shown in Figure 4. The 
wavelength for the maximum absorbance (λmax) of both the 
control and treated ashwagandha root extracts were at 205.3 
and 205.0 nm, respectively and there was a minor shift of 
absorbance maxima from the control sample (1.6140) to the 
treated sample (1.2553). It has been reported that the 
wavelength for the maximum absorbance for the 
ashwagandha root extract was at 208.50 nm [58]. However, 
no significant change in the λmax of the treated sample was 
observed compared to the control sample. The UV 
absorbance occurs due to the different type of energy 
transitions from the singlet to the singlet excited state such as 
σ → σ∗, n → π∗, π → π∗. These type of electronic transitions 
are occurred when the difference in energy between the 
lowest unoccupied molecular orbital (LUMO) and the 
highest occupied molecular orbital (HOMO) is significantly 
higher than the activation energy of the compound [59]. 
 
Figure 4. UV-vis spectra of the control and Biofield Energy Treated W. 
somnifera (Ashwagandha) root extracts.Hence, it is anticipated that the 
structure of the phytoconstituents in the treated sample was remained 
unaffected as compared to the control sample. 
3.5. Thermal Gravimetric Analysis (TGA) 
TGA was applied to investigate the thermal stability of the 
both control and treated ashwagandha root extracts. The TGA 
analysis exhibited three steps of thermal degradation as 
mentioned in Table 3 and Figure 5. In the 1st and 3rd step thermal 
degradation, the weight loss of the treated ashwagandha root 
extract (1st step = 10.55% and 2nd step = 10.40%) were reduced 
by 4.09% and 4.32%, respectively compared with the control 
sample (1st step =11.00% and 2nd step = 10.87%). 
Table 3. Thermal degradation steps of the control and Biofield Energy 
Treated W. somnifera (Ashwagandha) root extract. 
S. No. 
Temperature (oC) % Weight loss % 
Change Control Treated Control Treated 
1st step of 
degradation 
185.00 185.00 11.00 10.55 -4.09 
2nd step of 
degradation 
485.00 485.00 56.59 57.00 0.72 
3rd step of 
degradation 
895.90 895.90 10.87 10.40 -4.32 
Total weight loss - - 78.46 77.95 -0.65 
*denotes the percentage change in the weight loss of the Biofield Energy 
Treated sample with respect to the control sample. 
Furthermore, the weight loss of the second step 
degradation of the treated ashwagandha root extract (57.00%) 
was decreased by 0.72% with respect to the control sample 
(56.59 %). However, the total weight loss of the treated 
sample (77.95%) was reduced by 0.65% from the control 
sample (78.46%). It is then anticipated that The Trivedi 
Effect® treatment might enhance the thermal stability of the 
ashwagandha root extract. 
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Figure 5. TGA thermograms of the control and Biofield Energy Treated W. somnifera (Ashwagandha) root extract. 
 
Figure 6. The DTG thermograms of the control and Biofield Energy Treated W. somnifera root extract. 
Similarly, the DTG thermograms of the control and treated 
samples disclosed maximum temperature (Tmax) at 381.90 
and 382.82°C, respectively (Figure 6). The onset and endset 
degradation temperature were 316.53 and 444.61°C, 
respectively for the control sample. The onset and end-set 
degradation temperature was observed to be 316.14 and 
445.50°C, respectively for the treated sample. The DTG 
analysis indicated that the decomposition temperature of the 
biofield treated W. somnifera was fractionally increased as 
compared to the control sample. Overall, TGA/DTG revealed 
miner decrease in mass loss and increase in Tmax of biofield 
treated W. somnifera as compared to the control sample. The 
current study indicated that there was an increased in the 
thermal stability of the biofield treated W. somnifera as 
compared to the control sample. 
3.6. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of both the control and treated 
ashwagandha root extract are presented in the Figure 7 and 
Table 4. The DSC thermogram of the control and Biofield 
Energy Treated samples indicated the presence of a broad 
endothermic inflection at 79.36 and 98.02ºC, respectively 
which is not the true melting point of the treated 
ashwagandha root extract. It may be the evaporation of the 
bound water present in the sample. 
 
Figure 7. DSC thermograms of the control and Biofield Energy Treated W. 
somnifera (Ashwagandha) root extract. 
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Table 4. The melting point (°C) and latent heat of fusion (J/G) values of the control and Biofield Energy Treated W. somnifera (Ashwagandha) root extract. 
Sample Onset vaporization 
temperature (Tonset) °C 
Peak vaporization 
temperature (Tpeak) °C 
Endset vaporization 
temperature (Tendset) °C 
Latent heat of vaporization 
(∆Hvaporization) J/g 
Control  42.05 79.36 114.87 171.60 
Biofield Energy Treated 59.70 98.02 125.00 239.96 
% Change* 41.97 23.51 8.82 39.84 
Tonset: Onset vaporization temperature, Tpeak: Peak vaporization temperature, Tendset: Endset vaporization temperature, ∆H: Latent heat of vaporization, 
adenotes 
the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
The onset, peak, and endset vaporization temperature of 
the Biofield Energy Treated sample were significantly 
improved by 41.97%, 23.51%, 8.82%, respectively as 
compared to the control sample. Similarly the latent heat 
vaporization (∆H) of the Biofield Energy Treated sample, 
also increased significantly by 39.84% as compared to the 
control sample (Table 4). However, the Biofield Energy 
Treated, and control W. somnifera indicated several 
endothermic peak around 200ºC respectively (Figure 6). 
Several small endothermic peaks were also observed in the 
thermogram of both in control and treated samples, which 
may be due to the multiple phytoconstituents present in the 
root extract in a very small concentration [60, 61]. In the 
Biofield Energy Treated sample the endothermic peak was 
sharp and significantly prominent as compared to the control 
sample (Figure 6). It is assumed that The Trivedi Effect® - 
Energy of Consciousness Healing Treatment might improve 
the intermolecular force in the treated sample, which 
probably increased the thermal stability of ashwagandha root 
extract.  
4. Conclusions 
The current research work revealed that The Trivedi 
Effect® - Energy of Consciousness Healing Treatment 
(Biofield Energy Healing) has the outstanding capability for 
reduction of the particle size of the ashwagandha root extract 
along with enhanced surface area. The particle size values at 
d10, d50, and d90 values of the treated sample were decreased 
by 8.41%, 0.51%, and 7.88%, respectively compared with the 
control sample. The surface area analysis revealed that the 
surface area of the treated sample was significantly increased 
by 5% as compared to the control sample. The FT-IR 
analysis revealed that The Trivedi Effect® - Energy of 
Consciousness Healing Treatment had an effect on the 
structural properties of the ashwagandha root extract by 
changing the force constant of its functional groups. The 
TGA analysis revealed that the total weight loss was 
decreased by 0.65% in the treated sample as compared to the 
control sample. The DSC analysis indicated that the onset, 
peak, and endset vaporization temperature of the treated 
sample were significantly increased by 41.97%, 23.51%, and 
8.82%, respectively as compared to the control sample. The 
latent heat of vaporization (∆H) of the treated (239.96 J/g) 
sample was significantly increased by 39.84% compared with 
the control (171.60 J/g) sample. The DSC/TGA analysis 
indicated that the treated sample thermally more stable as 
compared to the control sample. In summary, The Trivedi 
Effect® treated ashwagandha root extract could be more 
soluble, absorbable from the gut and more bioavailable as 
compared to the untreated compound and be suitable for any 
oral pharmaceutical and nutraceutical formulation which 
might be providing better therapeutic response against 
various diseases such as diabetes mellitus, allergies and 
septic shock; stress-related disorders like sleep disorder, 
insomnia, anxiety, depression, Attention Deficit Disorder 
(ADD), Attention Deficit Hyperactive Disorder (ADHD), 
mental restlessness (mind chattering), brain frog, low libido, 
impotency, lack of motivation, mood swings, fear of the 
future, confusion, migraines, headaches, forgetfulness, 
overwhelm, loneliness, worthlessness, indecisiveness, 
frustration, irritability, chronic fatigue, obsessive/compulsive 
behavior and panic attacks; inflammatory diseases and 
immunological disorders like Lupus, Systemic Lupus 
Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, 
Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, 
Chronic active hepatitis, Celiac Disease (gluten-sensitive 
enteropathy), Addison Disease, Crohn's disease, Graves’ 
Disease, Pernicious and Aplastic Anemia, Sjogren 
Syndrome, Irritable Bowel Syndrome (IBS), Multiple 
Sclerosis, Rheumatoid arthritis, Chronic periodontitis, 
Ulcerative colitis, Chronic sinusitis, Myasthenia Gravis, 
Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, 
Rheumatoid Arthritis, Reactive Arthritis, Alopecia Areata, 
Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue 
Syndrome and Vitiligo; aging-related diseases like 
cardiovascular disease, arthritis, cancer, Alzheimer’s disease, 
dementia, cataracts, osteoporosis, diabetes, hypertension, 
glaucoma, hearing loss, Parkinson’s Disease, Huntington’s 
Disease, Prion Disease, Motor Neurone Disease, 
Spinocerebellar Ataxia, Spinal muscular atrophy, 
Amyotrophic lateral sclerosis, Friedreich’s Ataxia and Lewy 
Body Disease, chronic infections and many more. 
Abbreviations 
DSC: Differential scanning calorimetry, FT-IR: Fourier 
transform infrared spectroscopy, HOMO: Highest energy 
occupied molecular orbital, LUMO: Lowest energy 
unoccupied molecular orbital, TGA: Thermal gravimetric 
analysis, Tpeak = Peak vaporization temperature, ∆H: Latent 
heat of vaporization, UV-vis: Ultraviolet-visible 
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